Calcium for Hypertension

Verdict: Weak, clinically minor effect on blood pressure

Calcium supplements produce only a small, clinically minor drop in blood pressure and are not a treatment for high blood pressure; the strong calcium evidence applies to a different situation (preventing pre-eclampsia in pregnancy), not general adult hypertension.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

Pooled randomized data are consistent but the effect is too small to matter clinically. A 2022 Cochrane review (PMID 35014026, 18 trials, 3,140 people) found calcium lowered systolic pressure by only about 1.4 mmHg, and a 2006 meta-analysis (PMID 16673011, 40 trials) found roughly 1.9 mmHg, with diastolic effects often negligible. A 2006 review focused on people who already had hypertension (PMID 16625609) reported about a 2.5 mmHg systolic drop but concluded the causal evidence was weak and probably biased.

The benefit is concentrated in narrow subgroups, not the general patient. Reductions were largest in younger adults and in people with low baseline calcium intake (under about 800 mg/day), so calcium does not behave like a reliable blood-pressure treatment for the broader hypertensive population.

Health authorities back this cautious grade. The FDA endorses calcium only for bone health, the UK NHS advises getting calcium from a balanced diet rather than supplements, and the Mayo Clinic notes that large calcium doses can interact with certain blood-pressure drugs (milk-alkali risk with thiazide diuretics). The genuinely strong evidence (PMID 30277579, pre-eclampsia prevention in low-calcium pregnant women) is a separate indication and should not be read as support for treating ordinary high blood pressure.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
79%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Calcium supplementation for prevention of primary hypertension
PMID: 35014026 2022 Cochrane SR n = 3,140
Finding: Across 18 trials (3,140 participants), increased calcium intake modestly reduced SBP (MD -1.37 mmHg, 95% CI -2.08 to -0.66) and DBP (MD -1.45 mmHg, 95% CI -2.23 to -0.67) in mostly normotensive people; larger effect in participants under 35 (SBP MD -1.86, DBP MD -2.50).
Government Effect size: MD SBP -1.37 mmHg; DBP -1.45 mmHg
View on PubMed
Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials
PMID: 16673011 2006 統合分析 n = 2,492
Finding: Across 40 trials (2,492 subjects), calcium supplementation reduced SBP -1.86 mmHg (95% CI -2.91 to -0.81) and DBP -0.99 mmHg (95% CI -1.61 to -0.37); reductions were larger in people with low baseline calcium intake (<=800 mg/day): SBP -2.63 mmHg, DBP -1.30 mmHg.
Effect size: MD SBP -1.86 mmHg; DBP -0.99 mmHg
View on PubMed
Calcium supplementation for the management of primary hypertension in adults
PMID: 16625609 2006 統合分析 n = 485
Finding: Across 13 RCTs (485 hypertensive participants, 8-15 weeks), calcium reduced SBP -2.5 mmHg (95% CI -4.5 to -0.6) but DBP change was not significant (-0.8 mmHg, 95% CI -2.1 to 0.4); authors concluded the evidence for a causal BP-lowering effect is weak and probably biased.
🟠 Limited quality Effect size: MD SBP -2.5 mmHg; DBP NS
View on PubMed
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
PMID: 30277579 2018 Cochrane SR n = 18,064
Finding: High-dose calcium (>=1 g/day) reduced pre-eclampsia risk (avg RR 0.45, 95% CI 0.31 to 0.65; 13 trials) and high blood pressure (RR 0.65, 95% CI 0.53 to 0.81); effect was greatest in women with low-calcium diets (RR 0.36, 95% CI 0.20 to 0.65). An anomalous increase in HELLP syndrome was noted (RR 2.67, 95% CI 1.05 to 6.82, low absolute numbers).
Government Effect size: RR pre-eclampsia 0.45 (high-dose); RR gestational hypertension 0.65
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis. source↗
L4b EU EFSA
Supportive
L4c UK NHS
Neutral
Adults aged 19 to 64 need 700mg of calcium a day. ... Taking high doses of calcium (more than 1,500mg a day) could lead to stomach pain and diarrhoea. ... You should be able to get all the calcium you need by eating a varied and balanced diet. source↗
L4d TW TFDA / 衛福部
Supportive
19 歲以上成人鈣質之每日建議攝取量為 1000 毫克;鈣之上限攝取量(UL)為每日 2500 毫克。 source↗
L4e WHO
Cautious
In populations with low dietary calcium intake, daily calcium supplementation (1.5 g-2.0 g oral elemental calcium) is recommended for pregnant women to reduce the risk of pre-eclampsia. source↗
L5a NIH Office of Dietary Supplements
Supportive
L5b Mayo Clinic
Neutral
In large amounts, calcium supplements may affect certain blood pressure medicines. source↗
L5c Cleveland Clinic
Neutral
L5d Harvard Health
Neutral
L5e Specialty Society (condition-mapped)
Neutral
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hypertension-INT-calcium-001 繁體中文版 →